以兹提米比
医学
心肌梗塞
他汀类
内科学
急性冠脉综合征
心脏病学
作者
Christopher P. Cannon,Michael A. Blazing,Robert P. Giugliano,Amy McCagg,Jennifer A. White,Pierre Théroux,Harald Darius,Basil S. Lewis,Ton Oude Ophuis,J. Wouter Jukema,Gaetano Maria De Ferrari,Witold Rużyłło,Paul De Lucca,Canqing Yu,Erin A. Bohula,Martin Craig,Stephen D. Wiviott,Andrew M. Tershakovec,Ming‐Shyan Lin,Eugene Braunwald
标识
DOI:10.1056/nejmoa1410489
摘要
When added to statin therapy, ezetimibe resulted in incremental lowering of LDL cholesterol levels and improved cardiovascular outcomes. Moreover, lowering LDL cholesterol to levels below previous targets provided additional benefit. (Funded by Merck; IMPROVE-IT ClinicalTrials.gov number, NCT00202878.).
科研通智能强力驱动
Strongly Powered by AbleSci AI